# Bioharvest Sciences Inc.: Form 40-F for the period ended Dec 31, 2024

- Company: [Bioharvest Sciences Inc.](/companies/bhst.md) (CIK 1723464)
- Form: 40-F
- Filed: 2025-03-31
- Accepted by EDGAR: Mar 31, 2025, 17:08 ET
- Period: 2024-12-31
- Accession: 0001376474-25-000299
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723464/000137647425000299/bhst-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723464/000137647425000299/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $25.2m | us-gaap:Revenues |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $11.2m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $13.9m | ifrs-full:GrossProfit |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$7.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $8.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −$12.9m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.80 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −$6.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $2.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $2.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $7.9m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $25.0m | ifrs-full:Assets |
| Current liabilities | at 2024-12-31 | $14.3m | us-gaap:LiabilitiesCurrent |
| Short-term borrowings | at 2024-12-31 | $3.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-12-31 | $1.3m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2024-12-31 | 17,327,716 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723464/000137647425000299/bhst-20241231.htm

Filed Mar 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001376474-25-000299. Last ingested by Listed: Oct 29, 2026, 16:46 ET. No prices; not investment advice.